Showing results (1101-1110 of 2,857) with videos related to

Sort By:
Pageof 286
Pathology Oncology Research : POR|July 7, 2017
Estrogen Receptor β as a Prognostic Marker of Tumor Progression in Colorectal Cancer with Familial Adenomatous Polyposis and Sporadic PolypsPaulo Roberto Stevanato Filho, Samuel Aguiar Júnior, Maria Dirlei Begnami, et al.
Pathology Oncology Research : POR|September 27, 2017
Molecular Subgroups of Glioblastoma- an Assessment by Immunohistochemical MarkersÁdám Nagy, Ferenc Garzuly, Gergely Padányi, et al.
Pathology Oncology Research : POR|February 4, 2019
Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient ProgramGergely Varga, Zsolt Nagy, Judit Demeter, et al.
Pathology Oncology Research : POR|February 4, 2019
Comparison of Capecitabine (Xeloda) vs. Combination of Capecitabine and Oxaliplatin (XELOX) as Neoadjuvant CRT for Locally Advanced Rectal CancerAli Yaghobi Joybari, Payam Azadeh, Siamak Babaei, et al.
Pathology Oncology Research : POR|December 13, 2018
Sonic Hedgehog Protein is Frequently Up-Regulated in Pancreatic Cancer Compared to Colorectal CancerMadiha Niyaz, Mosin S Khan, Rauf A Wani, et al.
Pathology Oncology Research : POR|December 13, 2018
Identification of Long Noncoding RNA MIR22HG as a Novel Biomarker in Thyroid CancerLu Qin, Jin-Zhu Luo, Xue-Lian Tang, et al.
Pathology Oncology Research : POR|October 28, 2019
Renal Cell Carcinoma with Clear Cell Papillary Features: Perspectives of a Differential DiagnosisÁron Somorácz, Levente Kuthi, Tamás Micsik, et al.
Pathology Oncology Research : POR|March 30, 2018
Genetic Polymorphisms in miR-146a, miR-196a2 and miR-125a Genes and its Association in Prostate CancerMohan Damodaran, Solomon F D Paul, Vettriselvi Venkatesan
Pathology Oncology Research : POR|February 5, 2020
mTOR in Lung NeoplasmsIldiko Krencz, Anna Sebestyen, Andras Khoor
Pathology Oncology Research : POR|December 20, 2019
Increased Expression of Gankyrin and Stemness Factor Oct-4 are Associated with Unfavorable Clinical Outcomes and Poor Benefit of Tamoxifen in Breast Carcinoma PatientsRosa Jahangiri, Fatemeh Mosaffa, Amirnader EmamiRazavi, et al.
Pageof 286